Delivery Order SPE2DB22D2206-SPE2DB23FJY72
Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $2.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,419.59 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50 mg XCOPRI tablets. Under this single award, Amerisourcebergen will deliver 30 tablets to a location in Conshohocken, Pennsylvania by June 27, 2023 to fulfill the Defense Logistics Agency's requirements. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen supports the DLA's logistics operations to ensure critical medications reach...
- The Defense Logistics Agency awarded a $3,536.88 delivery order to AmerisourceBergen Drug Corp for XCOPRI 25 mg tablets (30-count units) with a firm fixed price structure. The contract, which was competitively awarded without set-aside designation, is scheduled for completion by June 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,300 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg tablets of XCOPRI. The prime contractor will deliver 30 tablets to a location in Conshohocken, Pennsylvania, with performance required between August 1-2, 2023. Amerisourcebergen Corporation is the parent company for this order placed against an existing DLA contract vehicle. As a leading provider of pharmaceuticals and medical supplies to the Department of Defense, this...
- The Defense Logistics Agency awarded a $1,813 delivery order to Amerisourcebergen Drug Corporation for 30 tablets of the 200 mg XCOPRI medication. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DOD components. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on September 19, 2023. The firm fixed price order was awarded competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,874.46 to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed-price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $4,051.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the purchase of 100mg XCOPRI tablets. Under this contract, Amerisourcebergen will deliver 30 tablets of the prescribed medication to a location in Conshohocken, Pennsylvania by July 24, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. No subcontractors or set aside designations were identified. The Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,165 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 50 mg tablets of XCOPRI to the agency. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day from September 7 to 8, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery vehicle such as prime vendor arrangements to streamline...
- The Defense Logistics Agency awarded a $1,768.44 delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count supply) under a firm fixed price contract type. The award was issued on June 2, 2025, with an ultimate completion date of June 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 150 MG tablets (30-count units) with a ceiling value of $1,830.53. This firm fixed-price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XCOPRI 50 mg tablets (30-count) with a ceiling value of $1,786.08. This firm fixed-price delivery order, issued on April 24, 2025, with a completion date of April 25, 2025, was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJY72Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $2,435 to Amerisourcebergen Drug Corporation to supply 50mg tablets of XCOPRI. The delivery order was issued against an existing DLA contract vehicle to provide pharmaceutical products and services to the Department of Defense. Amerisourcebergen will deliver 30 tablets of XCOPRI to a facility in Conshohocken, Pennsylvania by August 28, 2023 to fulfill requirements under this order. No subcontractors or set-aside designations were identified. The award draws upon the DLA's responsibility to procure and distribute medical supplies for military treatment facilities worldwide.
Generated 12/19/23, 6:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/25/23 |